Status:
NOT_YET_RECRUITING
Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Cornell University
Conditions:
Meningioma
Eligibility:
All Genders
18-89 years
Phase:
PHASE2
Brief Summary
The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.
Detailed Description
The investigator is proposing a direct comparison of Ga-68-DOTATATE and -DOTATOC in a pilot cohort of patients with meningioma, and hypothesize non-inferiority of DOTATOC. This pilot study will form t...
Eligibility Criteria
Inclusion
- Adult patients with clinically suspected meningioma
- Patients planned for surgery - undergoing preoperative workup
- No contraindications to either radiotracer
Exclusion
- Age less than 18 years
- Inability to lay on the scanner table for the required period of time, e.g., due to bone pain or claustrophobia.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04298541
Start Date
January 1 2026
End Date
January 1 2027
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medical College of Cornell University
New York, New York, United States, 10021